These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

683 related items for PubMed ID: 29630981

  • 1. Nerve Growth Factor Levels are Associated with Overactive Bladder Symptoms and Long-Term Treatment Outcome after Transurethral Resection of the Prostate in Patients with Benign Prostatic Hyperplasia.
    Hu H, Zhang W, Liu X, Wang H, Fang Z, Liang C, Wang T, Xu K.
    J Urol; 2018 Sep; 200(3):620-625. PubMed ID: 29630981
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH, Gilling PJ, Kennett KM, Frampton C, Westenberg AM, Fraundorfer MR.
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [Abstract] [Full Text] [Related]

  • 6. Can prostate stents be used to predict the outcome of transurethral resection of the prostate in the difficult cases?
    Knutson T.
    Curr Opin Urol; 2004 Jan; 14(1):35-9. PubMed ID: 15091048
    [Abstract] [Full Text] [Related]

  • 7. Overactive bladder changes with time: a 5-year longitudinal followup of changes in overactive bladder symptoms, urodynamic studies and urinary nerve growth factor levels.
    Chuang FC, Liu HT, Wang LY, Kuo HC.
    J Urol; 2014 Aug; 192(2):458-63. PubMed ID: 24594404
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate.
    Van Venrooij GE, Van Melick HH, Eckhardt MD, Boon TA.
    J Urol; 2002 Aug; 168(2):605-9. PubMed ID: 12131318
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Functional outcomes of transurethral thulium laser enucleation versus bipolar transurethral resection for benign prostatic hyperplasia over a period of 12 months: A prospective randomized study.
    Shoji S, Hanada I, Otaki T, Ogawa T, Yamada K, Uchida T, Higure T, Kawakami M, Kim H, Nitta M, Hasegawa M, Kawamura Y, Miyajima A.
    Int J Urol; 2020 Nov; 27(11):974-980. PubMed ID: 33241599
    [Abstract] [Full Text] [Related]

  • 13. Intravesical prostatic protrusion can predict therapeutic response to silodosin in male patients with lower urinary tract symptoms.
    Matsukawa Y, Ishida S, Majima T, Funahashi Y, Sassa N, Kato M, Yoshino Y, Gotoh M.
    Int J Urol; 2017 Jun; 24(6):454-459. PubMed ID: 28370376
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictive value of resistive index, detrusor wall thickness and ultrasound estimated bladder weight regarding the outcome after transurethral prostatectomy for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Huang T, Qi J, Yu YJ, Xu D, Jiao Y, Kang J, Chen YQ, Zhu YK.
    Int J Urol; 2012 Apr; 19(4):343-50. PubMed ID: 22220830
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome.
    Kim SR, Moon YJ, Kim SK, Bai SW.
    Yonsei Med J; 2015 Jan; 56(1):204-11. PubMed ID: 25510766
    [Abstract] [Full Text] [Related]

  • 19. Analysis of bladder vascular resistance before and after prostatic surgery in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Wada N, Watanabe M, Kita M, Matsumoto S, Kakizaki H.
    Neurourol Urodyn; 2012 Jun; 31(5):659-63. PubMed ID: 22488529
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.